GA option bar image

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

Show Description +

Can rapid GA progression reshape follow-up and dosing decisions? Case presenter Margaret Chang, MD, MS, shares the case of an 82-year-old casino owner with foveal-involving GA in his right eye. Moderator John Kitchens, MD, and panelists Ferhina Ali, MD, MPH and David Eichenbaum, MD, review how to rely on imaging to help explain GA progression, discuss why selecting every-other-month versus monthly therapy is sometimes useful, and ask whether continuing treating the worse-seeing eye is warranted when vision become very bad. The team also covers caregiver engagement, leveraging manufacturer patient-facing literature, and why annual follow-ups can miss fast GA progression.

Posted: 9/24/2025

Up Next

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH


Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Patient Selection for GA Treatments

David RP Almeida, MD, PhD, MBA; Chris Riemann, MD; and Lisa Faia, MD

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

Can rapid GA progression reshape follow-up and dosing decisions? Case presenter Margaret Chang, MD, MS, shares the case of an 82-year-old casino owner with foveal-involving GA in his right eye. Moderator John Kitchens, MD, and panelists Ferhina Ali, MD, MPH and David Eichenbaum, MD, review how to rely on imaging to help explain GA progression, discuss why selecting every-other-month versus monthly therapy is sometimes useful, and ask whether continuing treating the worse-seeing eye is warranted when vision become very bad. The team also covers caregiver engagement, leveraging manufacturer patient-facing literature, and why annual follow-ups can miss fast GA progression.

Posted: 9/24/2025


Please log in to leave a comment.